Short answer · Medically reviewed summary · Last updated: 2026-05-08
Prostate cancer is most commonly referred to by that name, though it is occasionally documented in medical records as prostatic carcinoma, prostatic adenocarcinoma, or simply by the abbreviation PCa. While these terms are used interchangeably, prostate cancer is the standard nomenclature used in clinical practice and global health reporting to describe the malignant growth of cells within the prostate gland. What are the common synonyms and abbreviations for prostate cancer? While prostate cancer is the universally recognized term, you may encounter several variations depending on the context of your medical records or historical research: Prostatic adenocarcinoma: The most frequent histological subtype, often used in pathology reports. Prostatic carcinoma: A general term describing malignant tumors originating in the prostate. PCa or PrCa: Standard medical abbreviations used in clinical notes and oncology research. Carcinoma of the prostate: A formal descriptive term often found in older medical literature or international registries. Why does prostate cancer have multiple names? The existence of multiple names for prostate cancer stems from a combination of anatomical specificity and histological classification.
Prostate cancer is most commonly referred to by that name, though it is occasionally documented in medical records as prostatic carcinoma, prostatic adenocarcinoma, or simply by the abbreviation PCa. While these terms are used interchangeably, prostate cancer is the standard nomenclature used in clinical practice and global health reporting to describe the malignant growth of cells within the prostate gland.
While prostate cancer is the universally recognized term, you may encounter several variations depending on the context of your medical records or historical research:
The existence of multiple names for prostate cancer stems from a combination of anatomical specificity and histological classification. Medical professionals prefer prostate cancer for patient communication due to its clarity, while pathologists use "prostatic adenocarcinoma" to specify that the cancer originated in the glandular cells. Historically, older texts may refer to the condition simply as "enlargement of the prostate," which is now recognized as a distinct, non-malignant condition known as Benign Prostatic Hyperplasia (BPH).
Standardized classification is vital for global tracking. In the International Classification of Diseases (ICD-10 and ICD-11), prostate cancer is categorized under malignant neoplasms of the male genital organs.
Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment.